Indranil Chakraborty
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Indranil Chakraborty has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Kuntal Pal
Department of Bio-Sciences, School of Bio Sciences and Technology (SBST), Vellore Institute of Technology, Vellore, India
2 shared publications - Oindrilla Dutta Gupta
Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication - Rahul Shaw
Department of Bio-Sciences, School of Bio Sciences and Technology (SBST), Vellore Institute of Technology, Vellore, India
1 shared publication
Latest Publications
- 29 January 2026
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 47 (5) , 1077-1102
A structural overview of G-protein-coupled receptors in neurological disorders
Neuropsychiatry and neurodegenerative disorders (NPDs and NDDs) are often associated with various physiological factors. It is increasingly apparent that signal transducers like G-protein-coupled receptors (GPCRs) are critical in disease progression and constitute an important class of drug targets. Several members of class A, class B, and class C GPCR families, along with their cognate binding partners, are involved in neurotransmission and neuromodulation. The vast information about the different molecular states of these GPCRs with their signaling complexes unravels the understanding of residual specificity in these protein-protein interactions and the dynamicity of transmembrane helices. The atypical mode of interaction of GPCRs with binding partners provides valuable insights for GPCR-conformation-based drug designing. In this review, we highlight the structural features of the serotonin, dopamine, and corticotropin receptors, namely 5-HTR1A, 5-HTR1B, 5-HTR2A, 5-HTR2B, 5-HTR2C, 5-HTR4, 5-HTR6, 5-HTR7, D1-5R, and CRF1-2R when forming transient complexes with G-proteins and arrestins. The distinct structural characteristics of these receptors explain the underlying molecular mechanism for signaling specificity and related physiological processes. This review also summarizes the importance of these structural insights in developing newer and effective pharmacologically biased drugs that can mediate specific signaling pathways to GPCRs.
- 29 January 2026
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 47 (5) , 1077-1102
A structural overview of G-protein-coupled receptors in neurological disorders
Neuropsychiatry and neurodegenerative disorders (NPDs and NDDs) are often associated with various physiological factors. It is increasingly apparent that signal transducers like G-protein-coupled receptors (GPCRs) are critical in disease progression and constitute an important class of drug targets. Several members of class A, class B, and class C GPCR families, along with their cognate binding partners, are involved in neurotransmission and neuromodulation. The vast information about the different molecular states of these GPCRs with their signaling complexes unravels the understanding of residual specificity in these protein-protein interactions and the dynamicity of transmembrane helices. The atypical mode of interaction of GPCRs with binding partners provides valuable insights for GPCR-conformation-based drug designing. In this review, we highlight the structural features of the serotonin, dopamine, and corticotropin receptors, namely 5-HTR1A, 5-HTR1B, 5-HTR2A, 5-HTR2B, 5-HTR2C, 5-HTR4, 5-HTR6, 5-HTR7, D1-5R, and CRF1-2R when forming transient complexes with G-proteins and arrestins. The distinct structural characteristics of these receptors explain the underlying molecular mechanism for signaling specificity and related physiological processes. This review also summarizes the importance of these structural insights in developing newer and effective pharmacologically biased drugs that can mediate specific signaling pathways to GPCRs.
- 1 January 2026
- Published by Springer Nature in Neuroinformatics
- Vol. 24 (1) , 14
A Comprehensive Analysis of Inflammation Regulatory Biomarkers among three Neuropsychiatric Disorders using Transcriptomic Approach
- 1 January 2026
- Published by Springer Nature in Neuroinformatics
- Vol. 24 (1) , 14
A Comprehensive Analysis of Inflammation Regulatory Biomarkers among three Neuropsychiatric Disorders using Transcriptomic Approach